Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cipla
Colorcon
Fish and Richardson
Express Scripts
McKinsey
Fuji
QuintilesIMS
Moodys

Generated: October 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086989

« Back to Dashboard

NDA 086989 describes METHOCARBAMOL, which is a drug marketed by Marsam Pharms Llc, Watson Labs, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Luitpold, Monterey Pharms Llc, Mylan Institutional, Navinta Llc, Renaissance Ssa Llc, Sagent Pharms, Somerset Theraps Llc, Able, Am Therap, Ascot, Austarpharma Llc, Beximco Pharms Usa, Clonmel Hlthcare, Dbl Pharms, Fosun Pharma, Granules India Ltd, Heather, Hetero Labs Ltd Iii, Hikma Intl Pharms, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Kv Pharm, Lannett Co Inc, Mylan, Nylos, Oxford Pharms, Pioneer Pharms, Prinston Inc, Puracap Pharm, Purepac Pharm, Roxane, Sandoz, Solvay, Sun Pharm Industries, Superpharm, Tablicaps, Upsher Smith, Mcneil, Par Pharm, and Stevens J, and is included in seventy NDAs. It is available from fifty-nine suppliers. Additional details are available on the METHOCARBAMOL profile page.

The generic ingredient in METHOCARBAMOL is aspirin; methocarbamol. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; methocarbamol profile page.
Summary for 086989
Tradename:METHOCARBAMOL
Applicant:Prinston Inc
Ingredient:methocarbamol
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 086989
Medical Subject Heading (MeSH) Categories for 086989
Suppliers and Packaging for NDA: 086989
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHOCARBAMOL methocarbamol TABLET;ORAL 086989 ANDA KAISER FOUNDATION HOSPITALS 0179-0177 0179-0177-30 30 TABLET in 1 BOTTLE (0179-0177-30)
METHOCARBAMOL methocarbamol TABLET;ORAL 086989 ANDA Blenheim Pharmacal, Inc. 10544-773 10544-773-18 18 TABLET in 1 BOTTLE (10544-773-18)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Healthtrust
Cantor Fitzgerald
Deloitte
QuintilesIMS
Harvard Business School
Chinese Patent Office
Dow
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.